{"content":"<li class=\"n-box-item date-title\" data-end=\"1326171599\" data-start=\"1326085200\" data-txt=\"Wednesday, December 18, 2019\">Monday, January  9, 2012</li><li class=\"n-box-item sa-box-item\" data-id=\"109174\" data-ts=\"1326154805\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDFC\" target=\"_blank\">WDFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109174\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on WD-40 (NASDAQ:WDFC): FQ1 earnings dropped 25% Y/Y, as the company&#39;s bottom line...</a></h4><p>More on WD-40 (NASDAQ:<a href=\"https://seekingalpha.com/symbol/WDFC\" title=\"WD-40 Company\">WDFC</a>): <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/109143\">FQ1 earnings</a> dropped 25% Y/Y, as the company's bottom line continues to get hit, largely due to the impact of high commodity costs and an unfavorable mix of products weighing heavily on margins. Share <font color=\"red\">-8%</font> AH. </p><div class=\"tiny-share-widget\" data-id=\"109174\" data-linked=\"More on WD-40 (NASDAQ:WDFC): FQ1 earnings dropped 25% Y/Y, as the company&#39;s bottom line...\" data-tweet=\"$WDFC - More on WD-40 (NASDAQ:WDFC): FQ1 earnings dropped 25% Y/Y, as the company&#39;s bottom line continues to get hit, largely due to the impact of high commodity costs and an unfavorable mix of products weighing heavily on margins. Share -8% AH. https://seekingalpha.com/news/109174?source=tweet\" data-url=\"https://seekingalpha.com/news/109174\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109173\" data-ts=\"1326154228\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMSC\" target=\"_blank\">SMSC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109173\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Standard Microsystems (NASDAQ:SMSC): FQ3 comes in line on revenue, but misses on a per...</a></h4><p>More on Standard Microsystems (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SMSC\" title=\"Standard Microsystems Corporation\">SMSC</a>): <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/109145\">FQ3 comes in line</a> on revenue, but misses on a per share basis due to weak PC, industrial and other consumer product demand. The company also projects a steeper than historical seasonal sales decline due to a combination of continued weak demand and lower post holiday consumer product sales. Shares <font color=\"red\">-7.9%</font> AH. </p><div class=\"tiny-share-widget\" data-id=\"109173\" data-linked=\"More on Standard Microsystems (NASDAQ:SMSC): FQ3 comes in line on revenue, but misses on a per...\" data-tweet=\"$SMSC - More on Standard Microsystems (NASDAQ:SMSC): FQ3 comes in line on revenue, but misses on a per share basis due to weak PC, industrial and other consumer product demand. The company also projects a steeper than historical seasonal sales decline d... https://seekingalpha.com/news/109173?source=tweet\" data-url=\"https://seekingalpha.com/news/109173\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109170\" data-ts=\"1326153121\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QUIK\" target=\"_blank\">QUIK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109170\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">QuickLogic Corporation (NASDAQ:QUIK) slips in post-trading after saying Q4 revenue will come in...</a></h4><p>QuickLogic Corporation (NASDAQ:<a href=\"https://seekingalpha.com/symbol/QUIK\" title=\"QuickLogic Corporation\">QUIK</a>) slips in post-trading after saying Q4 revenue will come in below estimates. It now expects to earn approximately $4.3M, below Street consensus of $5M. Shares <font color=\"red\">-3.5%</font> AH. </p><div class=\"tiny-share-widget\" data-id=\"109170\" data-linked=\"QuickLogic Corporation (NASDAQ:QUIK) slips in post-trading after saying Q4 revenue will come in...\" data-tweet=\"$QUIK - QuickLogic Corporation (NASDAQ:QUIK) slips in post-trading after saying Q4 revenue will come in below estimates. It now expects to earn approximately $4.3M, below Street consensus of $5M. Shares -3.5% AH. https://seekingalpha.com/news/109170?source=tweet\" data-url=\"https://seekingalpha.com/news/109170\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109168\" data-ts=\"1326152196\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HMA\" target=\"_blank\">HMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109168\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Health Management Associates (NYSE:HMA) trades lower after hours, despite raising its Q4...</a></h4><p>Health Management Associates (NYSE:<a href=\"https://seekingalpha.com/symbol/HMA\" title=\"Health Management Associates Inc.\">HMA</a>) trades lower after hours, despite raising its Q4 outlook, citing improved cost controls and effective hospital partnerships that boosted its bottom line. The company now expects to earn an EPS of $0.25 to $0.26 per share on $1.58B in revenue, compared to the Street view of $1.58B in revenue and earnings of $0.18 per share. Shares <font color=\"red\">-2.6%</font> AH. </p><div class=\"tiny-share-widget\" data-id=\"109168\" data-linked=\"Health Management Associates (NYSE:HMA) trades lower after hours, despite raising its Q4...\" data-tweet=\"$HMA - Health Management Associates (NYSE:HMA) trades lower after hours, despite raising its Q4 outlook, citing improved cost controls and effective hospital partnerships that boosted its bottom line. The company now expects to earn an EPS of $0.25 to $... https://seekingalpha.com/news/109168?source=tweet\" data-url=\"https://seekingalpha.com/news/109168\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109167\" data-ts=\"1326151849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZNGA\" target=\"_blank\">ZNGA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109167\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zynga (ZNGA -9.2%) ended an ugly day trading 20% below its IPO price. Aside from Playdom&#39;s...</a></h4><p>Zynga (<a href=\"https://seekingalpha.com/symbol/ZNGA\" title=\"Zynga\">ZNGA</a> <font color=\"red\">-9.2%</font>) ended an ugly day trading 20% below its IPO price. Aside from Playdom's (NYSE:<a href=\"https://seekingalpha.com/symbol/DIS\" title=\"The Walt Disney Company\">DIS</a>) <a target=\"_blank\" href=\"http://allthingsd.com/20120109/disney-unveils-combat-game-on-facebook-based-on-marvels-superheroes/\">unveiling</a> of <em>Marvel: Avengers Alliance</em> for Facebook, there wasn't any noteworthy news to move shares. But bearish opinions are easy to find: <a target=\"_blank\" href=\"http://www.forbes.com/sites/davidthier/2012/01/09/why-zynga-is-doomed/\">Dave Thier</a> argues Zynga's problem is that rising customer expectations force it to develop more expensive games to generate the same amount of revenue, all while <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/106967\">competition grows</a>. </p><div class=\"tiny-share-widget\" data-id=\"109167\" data-linked=\"Zynga (ZNGA -9.2%) ended an ugly day trading 20% below its IPO price. Aside from Playdom&#39;s...\" data-tweet=\"$ZNGA $ZNGA $DIS - Zynga (ZNGA -9.2%) ended an ugly day trading 20% below its IPO price. Aside from Playdom&#39;s (NYSE:DIS) unveiling of Marvel: Avengers Alliance for Facebook, there wasn&#39;t any noteworthy news to move shares. But bearish opinions are easy ... https://seekingalpha.com/news/109167?source=tweet\" data-url=\"https://seekingalpha.com/news/109167\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109164\" data-ts=\"1326150485\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKS\" target=\"_blank\">BKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109164\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barnes &amp;amp; Noble (BKS +4.1%) pared some of the huge losses it saw last week following its FY12...</a></h4><p>Barnes &amp; Noble (<a href=\"https://seekingalpha.com/symbol/BKS\" title=\"Barnes &amp; Noble Inc\">BKS</a> <font color=\"green\">+4.1%</font>) pared some of the <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/108514\">huge losses</a> it saw last week following its FY12 warning/Nook spinoff announcement. A possible reason could be B&amp;N's introduction of Nook hardware discounts (I, II) for those who agree to a one-year subscription for either the New York Times (NYSE:<a href=\"https://seekingalpha.com/symbol/NYT\" title=\"New York Times Co.\">NYT</a>) or People Magazine. The subscriptions cost $240/year and $120/year, respectively. </p><div class=\"tiny-share-widget\" data-id=\"109164\" data-linked=\"Barnes &amp;amp; Noble (BKS +4.1%) pared some of the huge losses it saw last week following its FY12...\" data-tweet=\"$BKS $BKS $NYT - Barnes &amp; Noble (BKS +4.1%) pared some of the huge losses it saw last week following its FY12 warning/Nook spinoff announcement. A possible reason could be B&amp;N&#39;s introduction of Nook hardware discounts (I, II) for those who agree to a on... https://seekingalpha.com/news/109164?source=tweet\" data-url=\"https://seekingalpha.com/news/109164\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109159\" data-ts=\"1326148686\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GCO\" target=\"_blank\">GCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109159\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apparel retailer Genesco (NYSE:GCO) gains 2.9% AH after announcing same-store sales have risen...</a></h4><p>Apparel retailer Genesco (NYSE:<a href=\"https://seekingalpha.com/symbol/GCO\" title=\"Genesco Inc.\">GCO</a>) <font color=\"green\">gains 2.9%</font> AH after announcing same-store sales have risen 13% Y/Y thus far in its current quarter, fueled by the strong performance of its Journeys and Lids Sports brands. Due to the better-than-expected sales, Genesco now expects FQ4 (ends Jan. 28) EPS of $1.63-$1.68, above a $1.60 consensus. </p><div class=\"tiny-share-widget\" data-id=\"109159\" data-linked=\"Apparel retailer Genesco (NYSE:GCO) gains 2.9% AH after announcing same-store sales have risen...\" data-tweet=\"$GCO - Apparel retailer Genesco (NYSE:GCO) gains 2.9% AH after announcing same-store sales have risen 13% Y/Y thus far in its current quarter, fueled by the strong performance of its Journeys and Lids Sports brands. Due to the better-than-expected sales... https://seekingalpha.com/news/109159?source=tweet\" data-url=\"https://seekingalpha.com/news/109159\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109155\" data-ts=\"1326146776\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELX\" target=\"_blank\">ELX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109155\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Emulex (NYSE:ELX) gains 8.3% AH after announcing it expects FQ2 revenue of $127M-$128M and EPS...</a></h4><p>Emulex (NYSE:<a href=\"https://seekingalpha.com/symbol/ELX\" title=\"Emulex Corporation\">ELX</a>) <font color=\"green\">gains 8.3%</font> AH after announcing it expects FQ2 revenue of $127M-$128M and EPS of $0.24-$0.25, above a consensus of $124M and $0.17. The company, whose shares had been hit by concerns about <a target=\"_blank\" href=\"http://www.seattlepi.com/business/article/Emulex-says-Thailand-facility-ops-suspended-2226937.php\">Thai flooding exposure</a>, says its operations are now back to full capacity. Top rival QLogic (NASDAQ:<a href=\"https://seekingalpha.com/symbol/QLGC\" title=\"QLogic Corporation\">QLGC</a>) is <font color=\"green\">up 3.6%</font>. </p><div class=\"tiny-share-widget\" data-id=\"109155\" data-linked=\"Emulex (NYSE:ELX) gains 8.3% AH after announcing it expects FQ2 revenue of $127M-$128M and EPS...\" data-tweet=\"$ELX $ELX $QLGC - Emulex (NYSE:ELX) gains 8.3% AH after announcing it expects FQ2 revenue of $127M-$128M and EPS of $0.24-$0.25, above a consensus of $124M and $0.17. The company, whose shares had been hit by concerns about Thai flooding exposure, says ... https://seekingalpha.com/news/109155?source=tweet\" data-url=\"https://seekingalpha.com/news/109155\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109154\" data-ts=\"1326146107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MEAS\" target=\"_blank\">MEAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109154\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sensor maker Measurement Specialties (NASDAQ:MEAS) falls 3.3% AH after warning it expects FQ3...</a></h4><p>Sensor maker Measurement Specialties (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MEAS\" title=\"Measurement Specialties, Inc.\">MEAS</a>) <font color=\"red\">falls 3.3%</font> AH after warning it expects FQ3 revenue of ~$76M, below a consensus of $79.6M. In addition, the company is guiding for FQ4 revenue of $81M-$84M, below an $85.3M consensus. </p><div class=\"tiny-share-widget\" data-id=\"109154\" data-linked=\"Sensor maker Measurement Specialties (NASDAQ:MEAS) falls 3.3% AH after warning it expects FQ3...\" data-tweet=\"$MEAS - Sensor maker Measurement Specialties (NASDAQ:MEAS) falls 3.3% AH after warning it expects FQ3 revenue of ~$76M, below a consensus of $79.6M. In addition, the company is guiding for FQ4 revenue of $81M-$84M, below an $85.3M consensus. https://seekingalpha.com/news/109154?source=tweet\" data-url=\"https://seekingalpha.com/news/109154\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109152\" data-ts=\"1326145110\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRUS\" target=\"_blank\">CRUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109152\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">In a season filled with chipmaker warnings, Cirrus Logic (NASDAQ:CRUS) is preannouncing in the...</a></h4><p>In a season filled with <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/104825\">chipmaker warnings</a>, Cirrus Logic (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CRUS\" title=\"Cirrus Logic, Inc.\">CRUS</a>) is preannouncing in the opposite direction: the company says it expects FQ3 revenue of $122M, well above a consensus of $105.1M, and is also guiding for FQ4 revenue of $105M, above a $98.5M consensus. Cirrus' announcement could be another indication of <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/108602\">strong iPhone demand</a>, given it supplies an <a target=\"_blank\" href=\"http://www.chipworks.com/en/technical-competitive-analysis/resources/recent-teardowns/2011/10/our-predictions-confirmed-dialog-and-cirrus-get-design-wins-in-the-iphone-4s/\">audio codec chip</a> for the 4S. Shares <font color=\"green\">+7.4%</font> AH. </p><div class=\"tiny-share-widget\" data-id=\"109152\" data-linked=\"In a season filled with chipmaker warnings, Cirrus Logic (NASDAQ:CRUS) is preannouncing in the...\" data-tweet=\"$CRUS $AAPL - In a season filled with chipmaker warnings, Cirrus Logic (NASDAQ:CRUS) is preannouncing in the opposite direction: the company says it expects FQ3 revenue of $122M, well above a consensus of $105.1M, and is also guiding for FQ4 revenue of ... https://seekingalpha.com/news/109152?source=tweet\" data-url=\"https://seekingalpha.com/news/109152\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109149\" data-ts=\"1326144368\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KATE\" target=\"_blank\">KATE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109149\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Liz Claiborne (LIZ) announces lower guidance for 2012, saying it nows sees adjusted EBITDA...</a></h4><p>Liz Claiborne (LIZ) <a target=\"_blank\" href=\"http://lizclaiborneinc.com/web/guest/pressreleases\">announces</a> lower guidance for 2012, saying it nows sees adjusted EBITDA falling in a range of $125M-$140M - lower than its previous estimate of $130M-$150M. Shares <font color=\"red\">sink 8.9%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"109149\" data-linked=\"Liz Claiborne (LIZ) announces lower guidance for 2012, saying it nows sees adjusted EBITDA...\" data-tweet=\"$KATE - Liz Claiborne (LIZ) announces lower guidance for 2012, saying it nows sees adjusted EBITDA falling in a range of $125M-$140M - lower than its previous estimate of $130M-$150M. Shares sink 8.9% AH. https://seekingalpha.com/news/109149?source=tweet\" data-url=\"https://seekingalpha.com/news/109149\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109148\" data-ts=\"1326144271\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNPR\" target=\"_blank\">JNPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109148\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Juniper (NYSE:JNPR) drops 3.6% AH after warning it expects Q4 revenue of $1.1B-$1.2B and EPS of...</a></h4><p>Juniper (NYSE:<a href=\"https://seekingalpha.com/symbol/JNPR\" title=\"Juniper Networks\">JNPR</a>) <font color=\"red\">drops 3.6%</font> AH after warning it expects Q4 revenue of $1.1B-$1.2B and EPS of $0.26-$0.28, largely below a consensus of $1.19B and $0.34. In what appears to be a vindication of <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/106177\">negative comments</a> made last month by UBS, Juniper blames the shortfall on weak service provider demand, particularly in the U.S.. <a href=\"https://seekingalpha.com/symbol/CSCO\" title=\"Cisco Systems, Inc.\">CSCO</a> <font color=\"red\">-0.8%</font>. <a href=\"https://seekingalpha.com/symbol/CIEN\" title=\"Ciena Corporation\">CIEN</a> <font color=\"red\">-1.4%</font>. <a href=\"https://seekingalpha.com/symbol/FFIV\" title=\"F5 Networks, Inc.\">FFIV</a> <font color=\"red\">-1.1%</font>. <a href=\"https://seekingalpha.com/symbol/RVBD\" title=\"Riverbed Technology, Inc.\">RVBD</a> <font color=\"red\">-1.4%</font>. ALU <font color=\"red\">-1.3%</font>. </p><div class=\"tiny-share-widget\" data-id=\"109148\" data-linked=\"Juniper (NYSE:JNPR) drops 3.6% AH after warning it expects Q4 revenue of $1.1B-$1.2B and EPS of...\" data-tweet=\"$JNPR $JNPR $CSCO - Juniper (NYSE:JNPR) drops 3.6% AH after warning it expects Q4 revenue of $1.1B-$1.2B and EPS of $0.26-$0.28, largely below a consensus of $1.19B and $0.34. In what appears to be a vindication of negative comments made last month by U... https://seekingalpha.com/news/109148?source=tweet\" data-url=\"https://seekingalpha.com/news/109148\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109140\" data-ts=\"1326142632\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNPR\" target=\"_blank\">JNPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109140\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Networking stocks enjoy a big boost after Juniper (JNPR +5.4%) and F5 (FFIV +3.7%) get upbeat...</a></h4><p>Networking stocks enjoy a big boost after Juniper (<a href=\"https://seekingalpha.com/symbol/JNPR\" title=\"Juniper Networks\">JNPR</a> <font color=\"green\">+5.4%</font>) and F5 (<a href=\"https://seekingalpha.com/symbol/FFIV\" title=\"F5 Networks, Inc.\">FFIV</a> <font color=\"green\">+3.7%</font>) get <a target=\"_blank\" href=\"http://www.marketwatch.com/story/apple-hits-new-high-as-techs-slip-2012-01-09\">upbeat reviews</a> from Sanjiv Wadhani of Stifel Nicolaus, who says his checks \"show that the pipeline is solid, which should bodes  well for March quarter guidance.\" Juniper likely will report an in-line quarter, he says, noting that bookings appeared to pick up in December. </p><div class=\"tiny-share-widget\" data-id=\"109140\" data-linked=\"Networking stocks enjoy a big boost after Juniper (JNPR +5.4%) and F5 (FFIV +3.7%) get upbeat...\" data-tweet=\"$JNPR $JNPR $FFIV - Networking stocks enjoy a big boost after Juniper (JNPR +5.4%) and F5 (FFIV +3.7%) get upbeat reviews from Sanjiv Wadhani of Stifel Nicolaus, who says his checks &quot;show that the pipeline is solid, which should bodes well for March qua... https://seekingalpha.com/news/109140?source=tweet\" data-url=\"https://seekingalpha.com/news/109140\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109139\" data-ts=\"1326142617\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/P\" target=\"_blank\">P</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109139\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pandora Media (P +4.3%) is set go out near its highs after being initiated with a Buy on...</a></h4> Pandora Media (<a href='https://seekingalpha.com/symbol/P' title='Pandora Media'>P</a> <font color=\"green\">+4.3%</font>) is set go out near its highs after being <a target=\"_blank\" href=\"http://www.theflyonthewall.com/content_index.php?symbol=p&amp;days_back=30&amp;table=none\">initiated with a Buy</a> on valuation earlier at Needham. <div class=\"tiny-share-widget\" data-id=\"109139\" data-linked=\"Pandora Media (P +4.3%) is set go out near its highs after being initiated with a Buy on...\" data-tweet=\"$P - Pandora Media (P +4.3%) is set go out near its highs after being initiated with a Buy on valuation earlier at Needham. https://seekingalpha.com/news/109139?source=tweet\" data-url=\"https://seekingalpha.com/news/109139\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109137\" data-ts=\"1326142230\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PENN\" target=\"_blank\">PENN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109137\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Penn National Gaming (PENN +4.4%) gains after Credit Suisse adds the stock to its U.S. Focus...</a></h4><p>Penn National Gaming (<a href=\"https://seekingalpha.com/symbol/PENN\" title=\"Penn National Gaming, Inc.\">PENN</a> <font color=\"green\">+4.4%</font>) gains after Credit Suisse <a target=\"_blank\" href=\"http://www.theflyonthewall.com/content_index.php?symbol=penn&amp;days_back=30&amp;table=none\">adds the stock</a> to its U.S. Focus List, citing an attractive valuation and potential upside stemming from a strengthening U.S. consumer market and the potential of future projects, including three new casinos in Kansas City, Kansas and Toledo, Ohio. </p><div class=\"tiny-share-widget\" data-id=\"109137\" data-linked=\"Penn National Gaming (PENN +4.4%) gains after Credit Suisse adds the stock to its U.S. Focus...\" data-tweet=\"$PENN - Penn National Gaming (PENN +4.4%) gains after Credit Suisse adds the stock to its U.S. Focus List, citing an attractive valuation and potential upside stemming from a strengthening U.S. consumer market and the potential of future projects, inclu... https://seekingalpha.com/news/109137?source=tweet\" data-url=\"https://seekingalpha.com/news/109137\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109134\" data-ts=\"1326141537\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DNDN\" target=\"_blank\">DNDN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109134\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Dendreon (DNDN +8.8%) extend their amazing three-day run, up nearly 80% since...</a></h4><p>Shares of Dendreon (<a href=\"https://seekingalpha.com/symbol/DNDN\" title=\"Dendreon Corporation\">DNDN</a> <font color=\"green\">+8.8%</font>) extend their amazing <a target=\"_blank\" href=\"http://www.google.com/finance?q=NASDAQ%3ADNDN\">three-day run</a>, up nearly 80% since <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/108535\">pre-announcing</a> better-than-expected Q4 revenue and revealing growing sales of its Provenge prostate cancer therapy. <a target=\"_blank\" href=\"http://blogs.barrons.com/stockstowatchtoday/2012/01/09/dendreons-on-a-huge-run-following-preannouncement/\">Too much too fast?</a> William Blair's Katherine Xu \u201ccontinue[s] to be concerned with Provenge\u2019s eventual potential and profitability.\" </p><div class=\"tiny-share-widget\" data-id=\"109134\" data-linked=\"Shares of Dendreon (DNDN +8.8%) extend their amazing three-day run, up nearly 80% since...\" data-tweet=\"$DNDN - Shares of Dendreon (DNDN +8.8%) extend their amazing three-day run, up nearly 80% since pre-announcing better-than-expected Q4 revenue and revealing growing sales of its Provenge prostate cancer therapy. Too much too fast? William Blair&#39;s Kather... https://seekingalpha.com/news/109134?source=tweet\" data-url=\"https://seekingalpha.com/news/109134\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109132\" data-ts=\"1326141279\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HNT\" target=\"_blank\">HNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109132\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Health Net (HNT +3.3%) advances after announcing earlier it&#39;s selling its Medicare...</a></h4><p>Health Net (<a href=\"https://seekingalpha.com/symbol/HNT\" title=\"Health Net, Inc.\">HNT</a> <font color=\"green\">+3.3%</font>) advances after announcing earlier it's selling its Medicare prescription-drug plan business to CVS Caremark (<a href=\"https://seekingalpha.com/symbol/CVS\" title=\"CVS Health Corporation\">CVS</a> <font color=\"green\">+0.7%</font>) for approximately $160M in an all cash deal. </p><div class=\"tiny-share-widget\" data-id=\"109132\" data-linked=\"Health Net (HNT +3.3%) advances after announcing earlier it&#39;s selling its Medicare...\" data-tweet=\"$HNT $HNT $CVS - Health Net (HNT +3.3%) advances after announcing earlier it&#39;s selling its Medicare prescription-drug plan business to CVS Caremark (CVS +0.7%) for approximately $160M in an all cash deal. https://seekingalpha.com/news/109132?source=tweet\" data-url=\"https://seekingalpha.com/news/109132\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109129\" data-ts=\"1326140532\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEEL\" target=\"_blank\">SEEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109129\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apricus Bioscience (APRI +4.8%) trades higher after Abbott Laboratories (NYSE:ABT) signs an...</a></h4><p>Apricus Bioscience (APRI <font color=\"green\">+4.8%</font>) trades higher after Abbott Laboratories (NYSE:<a href=\"https://seekingalpha.com/symbol/ABT\" title=\"Abbott Laboratories\">ABT</a>) signs an exclusive licensing and marketing agreement with the company to sell Vitaros, Apricus' treatment for erectile dysfunction, in Canada. </p><div class=\"tiny-share-widget\" data-id=\"109129\" data-linked=\"Apricus Bioscience (APRI +4.8%) trades higher after Abbott Laboratories (NYSE:ABT) signs an...\" data-tweet=\"$SEEL $SEEL $ABT - Apricus Bioscience (APRI +4.8%) trades higher after Abbott Laboratories (NYSE:ABT) signs an exclusive licensing and marketing agreement with the company to sell Vitaros, Apricus&#39; treatment for erectile dysfunction, in Canada. https://seekingalpha.com/news/109129?source=tweet\" data-url=\"https://seekingalpha.com/news/109129\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109128\" data-ts=\"1326140130\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109128\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wall Street is starting to worry about Google (GOOG -4.1%) becoming hitched to a lemon after...</a></h4> Wall Street is <a target=\"_blank\" href=\"http://blogs.wsj.com/deals/2012/01/09/starting-to-worry-about-googles-motorola-deal\">starting to worry</a> about Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color=\"red\">-4.1%</font>) becoming hitched to a lemon after Motorola Mobility's (<a href='https://seekingalpha.com/symbol/MMI' title='Marcus & Millichap, Inc.'>MMI</a> <font color=\"red\">-0.7%</font>) <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/108918\">Q4 warning</a> reflects difficult competition among mobile device makers. Yes, acquiring MMI's patents is the \"least bad\" way  to counter Apple and Microsoft, Cowen's Jim Friedland says, but \"unfortunately, the patents are saddled with MMI's poorly  performing handset business.\" <div class=\"tiny-share-widget\" data-id=\"109128\" data-linked=\"Wall Street is starting to worry about Google (GOOG -4.1%) becoming hitched to a lemon after...\" data-tweet=\"$GOOG - Wall Street is starting to worry about Google (GOOG -4.1%) becoming hitched to a lemon after Motorola Mobility&#39;s (MMI -0.7%) Q4 warning reflects difficult competition among mobile device makers. Yes, acquiring MMI&#39;s patents is the &quot;least bad&quot; wa... https://seekingalpha.com/news/109128?source=tweet\" data-url=\"https://seekingalpha.com/news/109128\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109125\" data-ts=\"1326139023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVNW\" target=\"_blank\">AVNW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109125\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aviat Networks (AVNW +15.8%) ramps higher today after reafirming FQ2 revenue, saying it to...</a></h4><p>Aviat Networks (<a href=\"https://seekingalpha.com/symbol/AVNW\" title=\"Aviat Networks, Inc.\">AVNW</a> <font color=\"green\">+15.8%</font>) ramps higher today after reafirming FQ2 revenue, saying it to expects FQ2 revenue to be in the range of $100M - $110M. </p><div class=\"tiny-share-widget\" data-id=\"109125\" data-linked=\"Aviat Networks (AVNW +15.8%) ramps higher today after reafirming FQ2 revenue, saying it to...\" data-tweet=\"$AVNW - Aviat Networks (AVNW +15.8%) ramps higher today after reafirming FQ2 revenue, saying it to expects FQ2 revenue to be in the range of $100M - $110M. https://seekingalpha.com/news/109125?source=tweet\" data-url=\"https://seekingalpha.com/news/109125\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109124\" data-ts=\"1326138882\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COST\" target=\"_blank\">COST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109124\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Costco (COST -2.1%) shares are lowered to Underperform at Bernstein, which notes that the...</a></h4><p>Costco (<a href=\"https://seekingalpha.com/symbol/COST\" title=\"Costco Wholesale Corporation\">COST</a> <font color=\"red\">-2.1%</font>) shares are <a target=\"_blank\" href=\"http://localizedusa.com/2012/01/09/costco-cost-shares-downgraded-to-a-underperform-rating-by-sanford-c-bernstein-analysts/\">lowered</a> to Underperform at Bernstein, which notes that the warehouse-style retailer's  operating margins have come under pressure in the past two quarters.  \"We expect this pressure to persist, making current consensus forecasts  look far too optimistic,\" the firm says. </p><div class=\"tiny-share-widget\" data-id=\"109124\" data-linked=\"Costco (COST -2.1%) shares are lowered to Underperform at Bernstein, which notes that the...\" data-tweet=\"$COST - Costco (COST -2.1%) shares are lowered to Underperform at Bernstein, which notes that the warehouse-style retailer&#39;s operating margins have come under pressure in the past two quarters. &quot;We expect this pressure to persist, making current consens... https://seekingalpha.com/news/109124?source=tweet\" data-url=\"https://seekingalpha.com/news/109124\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109120\" data-ts=\"1326138134\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MPC\" target=\"_blank\">MPC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109120\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. refining margins are worse than previously thought, Simmons Co. says in lowering its Q4...</a></h4><p>U.S. refining margins are worse than previously thought, Simmons Co. says in <a target=\"_blank\" href=\"http://www.nasdaq.com/aspx/stock-market-news-story.aspx?storyid=20120109-00941&amp;title=simmons-lowers-expectations-on-4q-refining-earnings\">lowering its Q4 earnings forecasts</a> for the industry. The firm projects Marathon Petroleum's (<a href=\"https://seekingalpha.com/symbol/MPC\" title=\"Marathon Petroleum Corp.\">MPC</a> <font color=\"red\">-3.6%</font>) EPS at zero, down from its earlier estimate of $0.70, and Holly Frontier (<a href=\"https://seekingalpha.com/symbol/HFC\" title=\"HollyFrontier Corp.\">HFC</a> <font color=\"red\">-3.2%</font>) will post a $1.20 gain, down from $1.26. Other refiners, including Valero (<a href=\"https://seekingalpha.com/symbol/VLO\" title=\"Valero Energy Corporation\">VLO</a> <font color=\"red\">-3.3%</font>) and Delek (<a href=\"https://seekingalpha.com/symbol/DK\" title=\"Delek US Holdings, Inc.\">DK</a> <font color=\"red\">-4.7%</font>), also are lower. </p><div class=\"tiny-share-widget\" data-id=\"109120\" data-linked=\"U.S. refining margins are worse than previously thought, Simmons Co. says in lowering its Q4...\" data-tweet=\"$MPC $MPC $HFC - U.S. refining margins are worse than previously thought, Simmons Co. says in lowering its Q4 earnings forecasts for the industry. The firm projects Marathon Petroleum&#39;s (MPC -3.6%) EPS at zero, down from its earlier estimate of $0.70, a... https://seekingalpha.com/news/109120?source=tweet\" data-url=\"https://seekingalpha.com/news/109120\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109118\" data-ts=\"1326137702\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TDY\" target=\"_blank\">TDY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109118\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LeCroy (LCRY +17.5%) skyrockets after announcing it expects FQ2 (ended in December) revenue of...</a></h4><p>LeCroy (LCRY <font color=\"green\">+17.5%</font>) skyrockets after announcing it expects FQ2 (ended in December) revenue of $51.1M and EPS of $0.30; the latter is in-line, while the former beats consensus by $0.8M, assuaging fears that macro issues would affect demand for LeCroy's electronics testing gear. LeCroy also says its board has approved a new 5M share buyback, good for 30% of outstanding shares. (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/97846\">October report</a>) </p><div class=\"tiny-share-widget\" data-id=\"109118\" data-linked=\"LeCroy (LCRY +17.5%) skyrockets after announcing it expects FQ2 (ended in December) revenue of...\" data-tweet=\"$TDY - LeCroy (LCRY +17.5%) skyrockets after announcing it expects FQ2 (ended in December) revenue of $51.1M and EPS of $0.30; the latter is in-line, while the former beats consensus by $0.8M, assuaging fears that macro issues would affect demand for Le... https://seekingalpha.com/news/109118?source=tweet\" data-url=\"https://seekingalpha.com/news/109118\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109116\" data-ts=\"1326137472\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109116\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valeant Pharmaceuticals (VRX +2.6%) firms after Jefferies raises its 12-month price target to...</a></h4><p>Valeant Pharmaceuticals (VRX <font color=\"green\">+2.6%</font>) firms after Jefferies <a target=\"_blank\" href=\"http://www.theflyonthewall.com/content_index.php?symbol=vrx&amp;days_back=30&amp;table=none\">raises its 12-month price target</a> to $75 from $64, saying FY12 guidance was even better than its optimistic forecasts, and it's encouraged by the company's stated goal of becoming a top 15 Pharmaceutical company by the end of 2013. </p><div class=\"tiny-share-widget\" data-id=\"109116\" data-linked=\"Valeant Pharmaceuticals (VRX +2.6%) firms after Jefferies raises its 12-month price target to...\" data-tweet=\"$BHC - Valeant Pharmaceuticals (VRX +2.6%) firms after Jefferies raises its 12-month price target to $75 from $64, saying FY12 guidance was even better than its optimistic forecasts, and it&#39;s encouraged by the company&#39;s stated goal of becoming a top 15 ... https://seekingalpha.com/news/109116?source=tweet\" data-url=\"https://seekingalpha.com/news/109116\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109114\" data-ts=\"1326136475\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STJ\" target=\"_blank\">STJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109114\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">St. Jude Medical (STJ +3.1%) reaffirms Q4 EPS guidance and sees revenues in-line at $1.4B -...</a></h4><p>St. Jude Medical (<a href=\"https://seekingalpha.com/symbol/STJ\" title=\"St. Jude Medical, Inc.\">STJ</a> <font color=\"green\">+3.1%</font>) reaffirms Q4 EPS guidance and sees revenues in-line at $1.4B - \"better-than-feared\" and \"a sigh of relief,\" Leerink Swann says. But a 4% decline in Q4 cardiac rhythm sales suggests continued softness in the U.S. market for implantable  defibrillators, whose sales have slumped on concerns of overuse  and a Department of Justice investigation. </p><div class=\"tiny-share-widget\" data-id=\"109114\" data-linked=\"St. Jude Medical (STJ +3.1%) reaffirms Q4 EPS guidance and sees revenues in-line at $1.4B -...\" data-tweet=\"$STJ - St. Jude Medical (STJ +3.1%) reaffirms Q4 EPS guidance and sees revenues in-line at $1.4B - &quot;better-than-feared&quot; and &quot;a sigh of relief,&quot; Leerink Swann says. But a 4% decline in Q4 cardiac rhythm sales suggests continued softness in the U.S. marke... https://seekingalpha.com/news/109114?source=tweet\" data-url=\"https://seekingalpha.com/news/109114\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109112\" data-ts=\"1326135926\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ITMN\" target=\"_blank\">ITMN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109112\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of InterMune (ITMN +10.4%) go on an INHX-inspired tear. The firm offers a protease...</a></h4><p>Shares of InterMune (<a href=\"https://seekingalpha.com/symbol/ITMN\" title=\"InterMune, Inc.\">ITMN</a> <font color=\"green\">+10.4%</font>) go on an <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/108953\">INHX-inspired</a> tear. The firm offers a protease inhibitor <a target=\"_blank\" href=\"http://www.bioworld.com/content/bristol-myers-squibb-moves-acquire-inhibitex-25b-0\">used by</a> Roche's Hepatitis C treatment candidate.</p><div class=\"tiny-share-widget\" data-id=\"109112\" data-linked=\"Shares of InterMune (ITMN +10.4%) go on an INHX-inspired tear. The firm offers a protease...\" data-tweet=\"$ITMN - Shares of InterMune (ITMN +10.4%) go on an INHX-inspired tear. The firm offers a protease inhibitor used by Roche&#39;s Hepatitis C treatment candidate. https://seekingalpha.com/news/109112?source=tweet\" data-url=\"https://seekingalpha.com/news/109112\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109111\" data-ts=\"1326135715\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MR\" target=\"_blank\">MR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109111\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chinese medical device maker Mindray Medical (MR +6.4%) surges after preannouncing 2011 revenue...</a></h4><p>Chinese medical device maker Mindray Medical (<a href=\"https://seekingalpha.com/symbol/MR\" title=\"Mindray Medical International Limited\">MR</a> <font color=\"green\">+6.4%</font>) surges after preannouncing 2011 revenue of $878M, above a Street forecast of $856.8M. Mindray also expects its 2011 net income to rise at least 10% (current consensus is for 9% growth), and is guiding for 2012 revenue growth of at least 18% (consensus of 17.3%). (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/104897\">previously</a>) </p><div class=\"tiny-share-widget\" data-id=\"109111\" data-linked=\"Chinese medical device maker Mindray Medical (MR +6.4%) surges after preannouncing 2011 revenue...\" data-tweet=\"$MR $MR-OLD - Chinese medical device maker Mindray Medical (MR +6.4%) surges after preannouncing 2011 revenue of $878M, above a Street forecast of $856.8M. Mindray also expects its 2011 net income to rise at least 10% (current consensus is for 9% growth... https://seekingalpha.com/news/109111?source=tweet\" data-url=\"https://seekingalpha.com/news/109111\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109108\" data-ts=\"1326135078\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZLTQ\" target=\"_blank\">ZLTQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109108\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zeltiq Aesthetics (ZLTQ -6.6%) retreats after the firm announces that its CFO has retired and...</a></h4><p>Zeltiq Aesthetics (<a href=\"https://seekingalpha.com/symbol/ZLTQ\" title=\"ZELTIQ Aesthetics, Inc.\">ZLTQ</a> <font color=\"red\">-6.6%)</font> retreats after the firm announces that its CFO has retired and will be replaced internally. Shares are now flat for the year after seeing a decent spike last week.</p><div class=\"tiny-share-widget\" data-id=\"109108\" data-linked=\"Zeltiq Aesthetics (ZLTQ -6.6%) retreats after the firm announces that its CFO has retired and...\" data-tweet=\"$ZLTQ - Zeltiq Aesthetics (ZLTQ -6.6%) retreats after the firm announces that its CFO has retired and will be replaced internally. Shares are now flat for the year after seeing a decent spike last week. https://seekingalpha.com/news/109108?source=tweet\" data-url=\"https://seekingalpha.com/news/109108\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109104\" data-ts=\"1326134253\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109104\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Despite Netflix (NFLX +8.2%) rising over 30% already this year, Whitney Tilson reckons the stock...</a></h4> Despite Netflix (<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a> <font color=\"green\">+8.2%</font>) rising over 30% already this year, Whitney Tilson reckons the stock \"should go <a target=\"_blank\" href=\"http://www.cnbc.com//id/45928640\">crazy to the upside</a>.\" Tilson gives four reasons: the Street overreacted to the downside; Netflix is an easy acquisition for large players; its <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/109021\">new services</a> in the U.K. and Ireland; and U.S. subscriber growth is growing again. <div class=\"tiny-share-widget\" data-id=\"109104\" data-linked=\"Despite Netflix (NFLX +8.2%) rising over 30% already this year, Whitney Tilson reckons the stock...\" data-tweet=\"$NFLX - Despite Netflix (NFLX +8.2%) rising over 30% already this year, Whitney Tilson reckons the stock &quot;should go crazy to the upside.&quot; Tilson gives four reasons: the Street overreacted to the downside; Netflix is an easy acquisition for large players... https://seekingalpha.com/news/109104?source=tweet\" data-url=\"https://seekingalpha.com/news/109104\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109103\" data-ts=\"1326133638\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OLED\" target=\"_blank\">OLED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109103\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Universal Display (PANL +5%) is rallying, perhaps thanks to LG&#39;s unveiling at CES of a 55-inch,...</a></h4><p>Universal Display (<a href=\"https://seekingalpha.com/symbol/PANL\" title=\"Pangaea Logistics Solutions Ltd.\">PANL</a> <font color=\"green\">+5%</font>) is rallying, perhaps thanks to <a target=\"_blank\" href=\"http://www.engadget.com/2012/01/09/lgs-55-inch-worlds-largest-oled-hdtv-eyes-on/\">LG's unveiling</a> at CES of a 55-inch, 5mm-thick OLED TV, which it claims is the world's largest. The news is apparently overshadowing a <a target=\"_blank\" href=\"http://www.yomiuri.co.jp/dy/business/T120107003536.htm\">report</a> that Sony (NYSE:<a href=\"https://seekingalpha.com/symbol/SNE\" title=\"Sony Corporation\">SNE</a>) is exiting the consumer OLED TV market. DisplaySearch expects the OLED TV market to <a target=\"_blank\" href=\"http://www.displaysearch.com/cps/rde/xchg/displaysearch/hs.xsl/120106_oled_display_technology_moving_to_compete_in_the_tv_market.asp\">take off</a> in the coming years, as manufacturing advances lower currently-exorbitant prices. (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/108713\">previously</a>) </p><div class=\"tiny-share-widget\" data-id=\"109103\" data-linked=\"Universal Display (PANL +5%) is rallying, perhaps thanks to LG&#39;s unveiling at CES of a 55-inch,...\" data-tweet=\"$OLED $OLED $SNE - Universal Display (PANL +5%) is rallying, perhaps thanks to LG&#39;s unveiling at CES of a 55-inch, 5mm-thick OLED TV, which it claims is the world&#39;s largest. The news is apparently overshadowing a report that Sony (NYSE:SNE) is exiting t... https://seekingalpha.com/news/109103?source=tweet\" data-url=\"https://seekingalpha.com/news/109103\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109101\" data-ts=\"1326133195\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MS\" target=\"_blank\">MS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109101\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley (MS +1.6%) says it&#39;s getting a new legal head, appointing Eric Grossman to...</a></h4> Morgan Stanley (<a href='https://seekingalpha.com/symbol/MS' title='Morgan Stanley'>MS</a> <font color=\"green\">+1.6%</font>) says it's <a target=\"_blank\" href=\"http://www.bloomberg.com/news/2012-01-09/morgan-stanley-s-grossman-succeeds-barron-as-chief-legal-officer.html\">getting a new legal head</a>, appointing Eric Grossman to succeed Frank Barron as Chief Legal Officer. Barron will be retiring later this year. <div class=\"tiny-share-widget\" data-id=\"109101\" data-linked=\"Morgan Stanley (MS +1.6%) says it&#39;s getting a new legal head, appointing Eric Grossman to...\" data-tweet=\"$MS - Morgan Stanley (MS +1.6%) says it&#39;s getting a new legal head, appointing Eric Grossman to succeed Frank Barron as Chief Legal Officer. Barron will be retiring later this year. https://seekingalpha.com/news/109101?source=tweet\" data-url=\"https://seekingalpha.com/news/109101\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109099\" data-ts=\"1326132716\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRNX\" target=\"_blank\">TRNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109099\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tornier (TRNX +4.3%) jumps after announcing preliminary Q4 sales of $69M (+12.7% Y/Y), beating...</a></h4><p>Tornier (<a href=\"https://seekingalpha.com/symbol/TRNX\" title=\"Tornier BV\">TRNX</a> <font color=\"green\">+4.3%</font>) jumps after announcing preliminary Q4 sales of $69M (+12.7% Y/Y), beating Street estimates by $1.9M. The Dutch medical device maker's growth was driven by a 17.5% Y/Y increase in sales of prosthetics for extremities. </p><div class=\"tiny-share-widget\" data-id=\"109099\" data-linked=\"Tornier (TRNX +4.3%) jumps after announcing preliminary Q4 sales of $69M (+12.7% Y/Y), beating...\" data-tweet=\"$TRNX $TRNX-OLD - Tornier (TRNX +4.3%) jumps after announcing preliminary Q4 sales of $69M (+12.7% Y/Y), beating Street estimates by $1.9M. The Dutch medical device maker&#39;s growth was driven by a 17.5% Y/Y increase in sales of prosthetics for extremities. https://seekingalpha.com/news/109099?source=tweet\" data-url=\"https://seekingalpha.com/news/109099\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109094\" data-ts=\"1326131962\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMY\" target=\"_blank\">BMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109094\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Other Hepatitis C drug-developers&#39; shares rally on the back of Bristol-Myers (BMY -1.1%) plans...</a></h4> Other Hepatitis C drug-developers' shares rally on the back of Bristol-Myers (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color=\"red\">-1.1%</font>) <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/108953\">plans to buy</a> Inhibitex (<a href='https://seekingalpha.com/symbol/INHX' title='Inhibitex, Inc.'>INHX</a> <font color=\"green\">+141%</font>): Idenix Pharmaceuticals  (<a href='https://seekingalpha.com/symbol/IDIX' title='Idenix Pharmaceuticals, Inc.'>IDIX</a> <font color=\"green\">+34%</font>), Achillion Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ACHN' title='Achillion Pharmaceuticals, Inc.'>ACHN</a> <font color=\"green\">+16%</font>) and  Vertex Pharmaceuticals (<a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a> <font color=\"green\">+4%</font>). <div class=\"tiny-share-widget\" data-id=\"109094\" data-linked=\"Other Hepatitis C drug-developers&#39; shares rally on the back of Bristol-Myers (BMY -1.1%) plans...\" data-tweet=\"$BMY $BMY $INHX - Other Hepatitis C drug-developers&#39; shares rally on the back of Bristol-Myers (BMY -1.1%) plans to buy Inhibitex (INHX +141%): Idenix Pharmaceuticals (IDIX +34%), Achillion Pharmaceuticals (ACHN +16%) and Vertex Pharmaceuticals (VRTX +4%). https://seekingalpha.com/news/109094?source=tweet\" data-url=\"https://seekingalpha.com/news/109094\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109093\" data-ts=\"1326131704\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HMA\" target=\"_blank\">HMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109093\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Health Management (HMA -7.8%) head straight north after Susquehanna&#39;s AJ Rice advises...</a></h4> Shares of Health Management (<a href='https://seekingalpha.com/symbol/HMA' title='Health Management Associates Inc.'>HMA</a> <font color=\"red\">-7.8%</font>) head straight north after Susquehanna's AJ Rice <a target=\"_blank\" href=\"http://www.streetinsider.com/Analyst+Comments/Health+Management+%28HMA%29+Shares+Rebound+as+Susquehanna+Defends%2C+Says+Buy+the+Dip/7068098.html\" target=\"_blank\">advises</a> clients of the firm to buy on weakness. HMA was down over 12% earlier due to concerns about a CRT Capital report on a lawsuit from one of the firm's ex-auditors. <div class=\"tiny-share-widget\" data-id=\"109093\" data-linked=\"Shares of Health Management (HMA -7.8%) head straight north after Susquehanna&#39;s AJ Rice advises...\" data-tweet=\"$HMA - Shares of Health Management (HMA -7.8%) head straight north after Susquehanna&#39;s AJ Rice advises clients of the firm to buy on weakness. HMA was down over 12% earlier due to concerns about a CRT Capital report on a lawsuit from one of the firm&#39;s e... https://seekingalpha.com/news/109093?source=tweet\" data-url=\"https://seekingalpha.com/news/109093\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109092\" data-ts=\"1326131524\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRCD\" target=\"_blank\">BRCD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109092\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brocade Communications (BRCD +8.9%) is halted after skying on a Reuters report it has received...</a></h4> Brocade Communications (<a href='https://seekingalpha.com/symbol/BRCD' title='Brocade Communications Systems, Inc.'>BRCD</a> <font color=\"green\">+8.9%</font>) is halted after skying on a Reuters report it has <a target=\"_blank\" href=\"https://twitter.com/#!/Street_Insider/status/156432138835734529\" target=\"_blank\">received bids</a> from a \"handful\" of buyers. The firm has reportedly hired Qatalyst Partners (Frank Quattrone) to explore a sale. <div class=\"tiny-share-widget\" data-id=\"109092\" data-linked=\"Brocade Communications (BRCD +8.9%) is halted after skying on a Reuters report it has received...\" data-tweet=\"$BRCD - Brocade Communications (BRCD +8.9%) is halted after skying on a Reuters report it has received bids from a &quot;handful&quot; of buyers. The firm has reportedly hired Qatalyst Partners (Frank Quattrone) to explore a sale. https://seekingalpha.com/news/109092?source=tweet\" data-url=\"https://seekingalpha.com/news/109092\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109088\" data-ts=\"1326131076\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PYX\" target=\"_blank\">PYX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109088\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alliance One International (AOI +4.08%) says its Brazilian subsidiary Alliance One Brasil...</a></h4><p>Alliance One International (AOI <font color=\"green\">+4.08%</font>) says its Brazilian subsidiary Alliance One Brasil Exportadora de Tabacos has agreed to form a new joint venture with China Tabaco Internacional do Brasil. Under the agreement, Alliance One Brazil will transfer to the joint venture production contracts with approximately 6K integrated farmers for the upcoming 2011/12 crop. </p><div class=\"tiny-share-widget\" data-id=\"109088\" data-linked=\"Alliance One International (AOI +4.08%) says its Brazilian subsidiary Alliance One Brasil...\" data-tweet=\"$PYX - Alliance One International (AOI +4.08%) says its Brazilian subsidiary Alliance One Brasil Exportadora de Tabacos has agreed to form a new joint venture with China Tabaco Internacional do Brasil. Under the agreement, Alliance One Brazil will trans... https://seekingalpha.com/news/109088?source=tweet\" data-url=\"https://seekingalpha.com/news/109088\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109085\" data-ts=\"1326130540\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCZ\" target=\"_blank\">OCZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109085\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OCZ Technology (OCZ +2.3%) OCZ) today anounced that it has acquired privately-held SANRAD, a...</a></h4><p>OCZ Technology (<a href=\"https://seekingalpha.com/symbol/OCZ\" title=\"OCZ Technology Group Inc\">OCZ</a> <font color=\"green\">+2.3%</font>) <a href=\"https://seekingalpha.com/symbol/OCZ\" title=\"OCZ Technology Group Inc\">OCZ</a>) today anounced that it has acquired privately-held SANRAD, a provider of flash caching and virtualization software and hardware, for $15 million.\"&gt;acquires privately-held SANRAD, a provider of flash caching and virtualization software and hardware, for $15M in an all-stock transaction. </p><div class=\"tiny-share-widget\" data-id=\"109085\" data-linked=\"OCZ Technology (OCZ +2.3%) OCZ) today anounced that it has acquired privately-held SANRAD, a...\" data-tweet=\"$OCZ - OCZ Technology (OCZ +2.3%) OCZ) today anounced that it has acquired privately-held SANRAD, a provider of flash caching and virtualization software and hardware, for $15 million.&quot;&amp;gt;acquires privately-held SANRAD, a provider of flash caching and ... https://seekingalpha.com/news/109085?source=tweet\" data-url=\"https://seekingalpha.com/news/109085\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109083\" data-ts=\"1326130382\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSMT\" target=\"_blank\">PSMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109083\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PriceSmart (PSMT -3.2%) which was crushed on Friday after reporting weak FQ1 results, sells off...</a></h4><p>PriceSmart (<a href=\"https://seekingalpha.com/symbol/PSMT\" title=\"PriceSmart, Inc.\">PSMT</a> <font color=\"red\">-3.2%</font>) which was <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/108819\">crushed on Friday</a> after reporting <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/108762\">weak FQ1 results</a>, sells off again today after announcing same-store sales rose 19.9% Y/Y, and total sales rose 22.7%, in December. This compares with growth of 18.5% and 23.1%, respectively, in November. </p><div class=\"tiny-share-widget\" data-id=\"109083\" data-linked=\"PriceSmart (PSMT -3.2%) which was crushed on Friday after reporting weak FQ1 results, sells off...\" data-tweet=\"$PSMT - PriceSmart (PSMT -3.2%) which was crushed on Friday after reporting weak FQ1 results, sells off again today after announcing same-store sales rose 19.9% Y/Y, and total sales rose 22.7%, in December. This compares with growth of 18.5% and 23.1%, ... https://seekingalpha.com/news/109083?source=tweet\" data-url=\"https://seekingalpha.com/news/109083\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109078\" data-ts=\"1326129892\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RL\" target=\"_blank\">RL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109078\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman Sachs adds Ralph Lauren (RL +4.1%) to its Conviction Buy List, seeing upside potential...</a></h4><p>Goldman Sachs <a target=\"_blank\" href=\"http://www.marketwatch.com/story/goldman-sees-polo-back-in-the-saddle-2012-01-09\">adds</a> Ralph Lauren (<a href=\"https://seekingalpha.com/symbol/RL\" title=\"Ralph Lauren Corporation\">RL</a> <font color=\"green\">+4.1%</font>) to its Conviction Buy List, seeing upside potential for shares as inflation costs recede and Asia expansion looks promising. The take on RL follows a bullish theme (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/107615\">I</a>, <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/103751\">II</a>, <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/99591\">III</a>) across the luxury retail sector - largely viewed as relatively unfazed by a slumping global economy and discounting headaches.</p><div class=\"tiny-share-widget\" data-id=\"109078\" data-linked=\"Goldman Sachs adds Ralph Lauren (RL +4.1%) to its Conviction Buy List, seeing upside potential...\" data-tweet=\"$RL $TPR $TIF - Goldman Sachs adds Ralph Lauren (RL +4.1%) to its Conviction Buy List, seeing upside potential for shares as inflation costs recede and Asia expansion looks promising. The take on RL follows a bullish theme (I, II, III) across the luxury... https://seekingalpha.com/news/109078?source=tweet\" data-url=\"https://seekingalpha.com/news/109078\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109077\" data-ts=\"1326129296\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IGT\" target=\"_blank\">IGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109077\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">International Game Technology (IGT -3.2%) trades lower after Credit Suisse removes the stock...</a></h4> International Game Technology (<a href='https://seekingalpha.com/symbol/IGT' title='International Game Technology'>IGT</a> <font color=\"red\">-3.2%</font>) trades lower after Credit Suisse <a target=\"_blank\" href=\"http://www.theflyonthewall.com/content_index.php?symbol=igt&amp;days_back=30&amp;table=none\">removes the stock</a> from its Focus List but maintains its outperform rating, saying it no longer considers the stock to be one of its best ideas. <div class=\"tiny-share-widget\" data-id=\"109077\" data-linked=\"International Game Technology (IGT -3.2%) trades lower after Credit Suisse removes the stock...\" data-tweet=\"$IGT - International Game Technology (IGT -3.2%) trades lower after Credit Suisse removes the stock from its Focus List but maintains its outperform rating, saying it no longer considers the stock to be one of its best ideas. https://seekingalpha.com/news/109077?source=tweet\" data-url=\"https://seekingalpha.com/news/109077\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109075\" data-ts=\"1326129219\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AYI\" target=\"_blank\">AYI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109075\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lighting fixture maker Acuity Brands (AYI +11.8%) soars after reporting FQ1 (ended in November)...</a></h4><p>Lighting fixture maker Acuity Brands (<a href=\"https://seekingalpha.com/symbol/AYI\" title=\"Acuity Brands, Inc. (Holding Company)\">AYI</a> <font color=\"green\">+11.8%</font>) soars after reporting FQ1 (ended in November) sales of $474.3M (+12% Y/Y) and EPS of $0.74, beating Street estimates by $8.2M and $0.15. The company's operating margin rose 50 bps Y/Y, to 11.2%. Acuity is also reiterating its forecast for low-to-mid single-digit growth for the North American lighting market in its fiscal 2012. (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/105476\">previously</a>) </p><div class=\"tiny-share-widget\" data-id=\"109075\" data-linked=\"Lighting fixture maker Acuity Brands (AYI +11.8%) soars after reporting FQ1 (ended in November)...\" data-tweet=\"$AYI - Lighting fixture maker Acuity Brands (AYI +11.8%) soars after reporting FQ1 (ended in November) sales of $474.3M (+12% Y/Y) and EPS of $0.74, beating Street estimates by $8.2M and $0.15. The company&#39;s operating margin rose 50 bps Y/Y, to 11.2%. A... https://seekingalpha.com/news/109075?source=tweet\" data-url=\"https://seekingalpha.com/news/109075\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109071\" data-ts=\"1326128165\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCSA\" target=\"_blank\">CMCSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109071\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macquarie raises its rating on Comcast (CMCSA +2%) shares to Outperform from Neutral, citing...</a></h4><p>Macquarie <a target=\"_blank\" href=\"http://www.forbes.com/sites/ericsavitz/2012/01/09/comcast-macquarie-upgrades/\">raises its rating</a> on Comcast (<a href=\"https://seekingalpha.com/symbol/CMCSA\" title=\"Comcast Corporation\">CMCSA</a> <font color=\"green\">+2%</font>) shares to Outperform from Neutral, citing \"the strongest underlying metrics in the group, an improved capital returns outlook, and significant upside potential in  turning around NBCU.\" The firm sees \"significant upside\" for the stock despite already gaining 13% vs. 6% for the the sector in the past three months. (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/109026\">earlier</a>) </p><div class=\"tiny-share-widget\" data-id=\"109071\" data-linked=\"Macquarie raises its rating on Comcast (CMCSA +2%) shares to Outperform from Neutral, citing...\" data-tweet=\"$CMCSA - Macquarie raises its rating on Comcast (CMCSA +2%) shares to Outperform from Neutral, citing &quot;the strongest underlying metrics in the group, an improved capital returns outlook, and significant upside potential in turning around NBCU.&quot; The firm... https://seekingalpha.com/news/109071?source=tweet\" data-url=\"https://seekingalpha.com/news/109071\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109068\" data-ts=\"1326127568\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109068\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avago Technologies (AVGO +6.9%) spikes higher after Nomura and Deutsche both upgrade the analog...</a></h4><p>Avago Technologies (<a href=\"https://seekingalpha.com/symbol/AVGO\" title=\"Broadcom Limited\">AVGO</a> <font color=\"green\">+6.9%</font>) spikes higher after Nomura and Deutsche both upgrade the analog chipmaker. Nomura <a target=\"_blank\" href=\"http://www.streetinsider.com/Upgrades/UPDATE+-+Nomura+Securities+Upgraded+Avago+Technologies+%28AVGO%29+to+Buy%3B+Currently+Mispriced/7067497.html\">touts</a> Avago's low valuation, and thinks Street estimates are too low given rebounding industrial demand and the company's strong wireless position. An Avago power amplifier is <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/95704\">built into</a> the iPhone 4S. </p><div class=\"tiny-share-widget\" data-id=\"109068\" data-linked=\"Avago Technologies (AVGO +6.9%) spikes higher after Nomura and Deutsche both upgrade the analog...\" data-tweet=\"$AVGO - Avago Technologies (AVGO +6.9%) spikes higher after Nomura and Deutsche both upgrade the analog chipmaker. Nomura touts Avago&#39;s low valuation, and thinks Street estimates are too low given rebounding industrial demand and the company&#39;s strong wi... https://seekingalpha.com/news/109068?source=tweet\" data-url=\"https://seekingalpha.com/news/109068\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109066\" data-ts=\"1326127209\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRX\" target=\"_blank\">AMRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109066\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Impax Laboratories (IPXL +5.4%) catches a bid after Canaccord Genuity upgrades the firm to Buy...</a></h4><p>Impax Laboratories (IPXL <font color=\"green\">+5.4%</font>) catches a bid after Canaccord Genuity <a target=\"_blank\" href=\"http://www.streetinsider.com/Upgrades/Canaccord+Genuity+Upgrades+Impax+Laboratories+%28IPXL%29+to+Buy/7066972.html\">upgrades</a> the firm to Buy from Hold with a lofty price target of $28. Shares hit a 6-month high on the strength of the buying flurry.</p><div class=\"tiny-share-widget\" data-id=\"109066\" data-linked=\"Impax Laboratories (IPXL +5.4%) catches a bid after Canaccord Genuity upgrades the firm to Buy...\" data-tweet=\"$AMRX - Impax Laboratories (IPXL +5.4%) catches a bid after Canaccord Genuity upgrades the firm to Buy from Hold with a lofty price target of $28. Shares hit a 6-month high on the strength of the buying flurry. https://seekingalpha.com/news/109066?source=tweet\" data-url=\"https://seekingalpha.com/news/109066\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109064\" data-ts=\"1326126875\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AFL\" target=\"_blank\">AFL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109064\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aflac (AFL -3.7%) is cut to Sell from Neutral at UBS with a reduced price target of $34 from...</a></h4><p>Aflac (<a href=\"https://seekingalpha.com/symbol/AFL\" title=\"Aflac Incorporated\">AFL</a> <font color=\"red\">-3.7%</font>) is <a target=\"_blank\" href=\"http://www.schaeffersresearch.com/commentary/content/upgrades+downgrades+aapl+open+afl+tjx+and+anf/trading_floor_blog.aspx?blogid=109505\">cut to Sell</a> from Neutral at UBS with a reduced price target of $34 from $39, citing remaining overexposure to Europe despite de-risking efforts. UBS also  flags the potential for decelerating EPS growth at the insurer,  in part because the company could slow share buybacks if significant  European credit losses materialize. </p><div class=\"tiny-share-widget\" data-id=\"109064\" data-linked=\"Aflac (AFL -3.7%) is cut to Sell from Neutral at UBS with a reduced price target of $34 from...\" data-tweet=\"$AFL - Aflac (AFL -3.7%) is cut to Sell from Neutral at UBS with a reduced price target of $34 from $39, citing remaining overexposure to Europe despite de-risking efforts. UBS also flags the potential for decelerating EPS growth at the insurer, in part... https://seekingalpha.com/news/109064?source=tweet\" data-url=\"https://seekingalpha.com/news/109064\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109063\" data-ts=\"1326126813\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACOR\" target=\"_blank\">ACOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109063\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biotechnology firm Acorda Therapeutics (ACOR +4%) gains after saying that due to successful...</a></h4><p>Biotechnology firm Acorda Therapeutics (<a href=\"https://seekingalpha.com/symbol/ACOR\" title=\"Acorda Therapeutics, Inc.\">ACOR</a> <font color=\"green\">+4%</font>) gains after saying that due to successful marketing efforts, it expects sales of Ampyra to rise to $255M - $275M in 2012, up from $210M last year. </p><div class=\"tiny-share-widget\" data-id=\"109063\" data-linked=\"Biotechnology firm Acorda Therapeutics (ACOR +4%) gains after saying that due to successful...\" data-tweet=\"$ACOR - Biotechnology firm Acorda Therapeutics (ACOR +4%) gains after saying that due to successful marketing efforts, it expects sales of Ampyra to rise to $255M - $275M in 2012, up from $210M last year. https://seekingalpha.com/news/109063?source=tweet\" data-url=\"https://seekingalpha.com/news/109063\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109061\" data-ts=\"1326126375\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VEON\" target=\"_blank\">VEON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109061\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Russian carrier VimpelCom (VIP +2.6%) trades higher after announcing a memorandum of...</a></h4><p>Russian carrier VimpelCom (VIP <font color=\"green\">+2.6%</font>) trades higher after announcing a memorandum of understanding with the Algerian government regarding the sale by its Orascom subsidiary of a majority stake in local carrier Djezzy. Orascom, which is 51.7%-owned by VimpelCom of, has been <a target=\"_blank\" href=\"http://www.reuters.com/article/2012/01/09/vimpelcom-algeria-idUSL6E8C92HS20120109\">under pressure</a> to sell Djezzy after the Algerian government said it wants the carrier nationalized. A price still has to be determined. </p><div class=\"tiny-share-widget\" data-id=\"109061\" data-linked=\"Russian carrier VimpelCom (VIP +2.6%) trades higher after announcing a memorandum of...\" data-tweet=\"$VEON - Russian carrier VimpelCom (VIP +2.6%) trades higher after announcing a memorandum of understanding with the Algerian government regarding the sale by its Orascom subsidiary of a majority stake in local carrier Djezzy. Orascom, which is 51.7%-own... https://seekingalpha.com/news/109061?source=tweet\" data-url=\"https://seekingalpha.com/news/109061\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109060\" data-ts=\"1326126221\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDAS\" target=\"_blank\">MDAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109060\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tremblant Capital discloses a stake (13G) in SodaStream (MDAS -1.4%) of 9.79%, marking the first...</a></h4>Tremblant Capital discloses a stake (<a target=\"_blank\" href=\"http://www.sec.gov/Archives/edgar/data/1353312/000091957412000051/d1255705_13-g.htm\">13G</a>) in SodaStream (<a href='https://seekingalpha.com/symbol/MDAS' title='MedAssets, Inc.'>MDAS</a> <font color=\"red\">-1.4%</font>) of 9.79%, marking the first time it revealed an ownership position in the beverage carbonation systems manufacturer.<div class=\"tiny-share-widget\" data-id=\"109060\" data-linked=\"Tremblant Capital discloses a stake (13G) in SodaStream (MDAS -1.4%) of 9.79%, marking the first...\" data-tweet=\"$MDAS - Tremblant Capital discloses a stake (13G) in SodaStream (MDAS -1.4%) of 9.79%, marking the first time it revealed an ownership position in the beverage carbonation systems manufacturer. https://seekingalpha.com/news/109060?source=tweet\" data-url=\"https://seekingalpha.com/news/109060\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109059\" data-ts=\"1326126078\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMAG\" target=\"_blank\">AMAG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109059\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMAG Pharmaceuticals (AMAG -5.8%) trades lower after the company says it expects Q4 sales to...</a></h4><p>AMAG Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/AMAG\" title=\"AMAG Pharmaceuticals, Inc.\">AMAG</a> <font color=\"red\">-5.8%</font>) trades lower after the company says it expects Q4 sales to come in below consensus. It now expects revenue in the range of $14.3M - $15M, below analysts' estimates of $16M. </p><div class=\"tiny-share-widget\" data-id=\"109059\" data-linked=\"AMAG Pharmaceuticals (AMAG -5.8%) trades lower after the company says it expects Q4 sales to...\" data-tweet=\"$AMAG - AMAG Pharmaceuticals (AMAG -5.8%) trades lower after the company says it expects Q4 sales to come in below consensus. It now expects revenue in the range of $14.3M - $15M, below analysts&#39; estimates of $16M. https://seekingalpha.com/news/109059?source=tweet\" data-url=\"https://seekingalpha.com/news/109059\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109056\" data-ts=\"1326125444\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STE\" target=\"_blank\">STE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109056\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Steris (STE -4.1%) get stung by a downgrade from analysts at CL King who take their...</a></h4><p>Shares of Steris (<a href=\"https://seekingalpha.com/symbol/STE\" title=\"Steris Corporation\">STE</a> <font color=\"red\">-4.1%</font>) get stung by a <a target=\"_blank\" href=\"http://localizedusa.com/2012/01/09/steris-ste-shares-downgraded-to-a-sell-rating-by-cl-king-analysts/\">downgrade</a> from analysts at CL King who take their rating down on the infection prevention firm to Sell from Neutral. </p><div class=\"tiny-share-widget\" data-id=\"109056\" data-linked=\"Shares of Steris (STE -4.1%) get stung by a downgrade from analysts at CL King who take their...\" data-tweet=\"$STE - Shares of Steris (STE -4.1%) get stung by a downgrade from analysts at CL King who take their rating down on the infection prevention firm to Sell from Neutral. https://seekingalpha.com/news/109056?source=tweet\" data-url=\"https://seekingalpha.com/news/109056\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109055\" data-ts=\"1326125125\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATX\" target=\"_blank\">ATX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109055\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">High-end penmaker A.T. Cross (ATX -17.2%) tumbles after announcing it expects 2011 EPS of...</a></h4><p>High-end penmaker A.T. Cross (<a href=\"https://seekingalpha.com/symbol/ATX\" title=\"Costa Inc.\">ATX</a> <font color=\"red\">-17.2%</font>) tumbles after announcing it expects 2011 EPS of $0.62-$0.65 and 2012 EPS of $0.70-$0.75, below consensus estimates of $0.66 and $0.84, respectively. The company blames the 2011 shortfall on a 6% Y/Y revenue decline in its Accessory division in Q4, thanks to weak European sales. </p><div class=\"tiny-share-widget\" data-id=\"109055\" data-linked=\"High-end penmaker A.T. Cross (ATX -17.2%) tumbles after announcing it expects 2011 EPS of...\" data-tweet=\"$ATX - High-end penmaker A.T. Cross (ATX -17.2%) tumbles after announcing it expects 2011 EPS of $0.62-$0.65 and 2012 EPS of $0.70-$0.75, below consensus estimates of $0.66 and $0.84, respectively. The company blames the 2011 shortfall on a 6% Y/Y reven... https://seekingalpha.com/news/109055?source=tweet\" data-url=\"https://seekingalpha.com/news/109055\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109052\" data-ts=\"1326124915\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AA\" target=\"_blank\">AA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109052\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alcoa (AA +3.3%) gets a lift this morning from an article in Barron&#39;s over the weekend that...</a></h4><p>Alcoa (<a href=\"https://seekingalpha.com/symbol/AA\" title=\"Alcoa Corporation\">AA</a> <font color=\"green\">+3.3%</font>) gets a lift this morning from an article in <i>Barron's</i> over the weekend that suggests <a target=\"_blank\" href=\"http://online.barrons.com/article/SB50001424052748704158404577140633229367986.html?mod=googlenews_wsj?mod=googlenews_barrons\">aluminum prices may have bottomed</a> and the stock could benefit from bargain hunting as mining capacity is rationalized. Morgan Stanley's Paretosh Misra sees Alcoa as a defensive play with less downside risk to aluminium than other commodities. </p><div class=\"tiny-share-widget\" data-id=\"109052\" data-linked=\"Alcoa (AA +3.3%) gets a lift this morning from an article in Barron&#39;s over the weekend that...\" data-tweet=\"$AA - Alcoa (AA +3.3%) gets a lift this morning from an article in Barron&#39;s over the weekend that suggests aluminum prices may have bottomed and the stock could benefit from bargain hunting as mining capacity is rationalized. Morgan Stanley&#39;s Paretosh M... https://seekingalpha.com/news/109052?source=tweet\" data-url=\"https://seekingalpha.com/news/109052\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109050\" data-ts=\"1326124750\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMAX\" target=\"_blank\">IMAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109050\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IMAX (IMAX +4.4%) and Cinemas Guzzo announce a JV to install four digital IMAX theatre systems...</a></h4><p>IMAX (<a href=\"https://seekingalpha.com/symbol/IMAX\" title=\"IMAX Corporation\">IMAX</a> <font color=\"green\">+4.4%</font>) and Cinemas Guzzo announce a JV to install four digital IMAX theatre systems in Montreal, bringing the total number of theatres open or contracted to open in Canada to 30. Heard On The Street's John Jannarone thinks increasing demand for IMAX screens - with an order backlog of 580-600 by the end of 2012 - means <a target=\"_blank\" href=\"http://online.wsj.com/article/SB10001424052970204331304577144982974307406.html\">several years of growth</a>. </p><div class=\"tiny-share-widget\" data-id=\"109050\" data-linked=\"IMAX (IMAX +4.4%) and Cinemas Guzzo announce a JV to install four digital IMAX theatre systems...\" data-tweet=\"$IMAX - IMAX (IMAX +4.4%) and Cinemas Guzzo announce a JV to install four digital IMAX theatre systems in Montreal, bringing the total number of theatres open or contracted to open in Canada to 30. Heard On The Street&#39;s John Jannarone thinks increasing ... https://seekingalpha.com/news/109050?source=tweet\" data-url=\"https://seekingalpha.com/news/109050\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109049\" data-ts=\"1326124698\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HUM\" target=\"_blank\">HUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109049\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Metropolitan Health Networks (MDF +5.1%) shoots higher on heavy volume after the health care...</a></h4><p>Metropolitan Health Networks (MDF <font color=\"green\">+5.1%</font>) shoots higher on heavy volume after the health care provider sector sees <a target=\"_blank\" href=\"http://online.wsj.com/article/BT-CO-20120109-703698.html\">upward revisions</a> for medicare plans this year.</p><div class=\"tiny-share-widget\" data-id=\"109049\" data-linked=\"Metropolitan Health Networks (MDF +5.1%) shoots higher on heavy volume after the health care...\" data-tweet=\"$HUM - Metropolitan Health Networks (MDF +5.1%) shoots higher on heavy volume after the health care provider sector sees upward revisions for medicare plans this year. https://seekingalpha.com/news/109049?source=tweet\" data-url=\"https://seekingalpha.com/news/109049\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109046\" data-ts=\"1326123833\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HGG\" target=\"_blank\">HGG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109046\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hhgregg (HGG -4.1%) trades lower today after shares went on a roller coaster ride last week....</a></h4>Hhgregg (<a href='https://seekingalpha.com/symbol/HGG' title='hhgregg, Inc.'>HGG</a> <font color=\"red\">-4.1%</font>) trades lower today after shares went on a roller coaster ride last week. Schaeffer's Investment Research says all the hubbub <a target=\"_blank\" href=\"www.schaeffersresearch.com/marketcenters/optionscenter/content/options+traders+zero+in+on+hhgregg+calls/default.aspx\">is attributable</a> to some heavy options trading on the bearish side that's dominating action.<div class=\"tiny-share-widget\" data-id=\"109046\" data-linked=\"Hhgregg (HGG -4.1%) trades lower today after shares went on a roller coaster ride last week....\" data-tweet=\"$HGG - Hhgregg (HGG -4.1%) trades lower today after shares went on a roller coaster ride last week. Schaeffer&#39;s Investment Research says all the hubbub is attributable to some heavy options trading on the bearish side that&#39;s dominating action. https://seekingalpha.com/news/109046?source=tweet\" data-url=\"https://seekingalpha.com/news/109046\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109042\" data-ts=\"1326123481\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MED\" target=\"_blank\">MED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109042\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medifast (MED -2.9%) dips after an article in Barron&#39;s over the weekend says the company is...</a></h4> Medifast (<a href='https://seekingalpha.com/symbol/MED' title='Medifast, Inc.'>MED</a> <font color=\"red\">-2.9%</font>) dips after an article in <i>Barron's</i> over the weekend says the company is <a target=\"_blank\" href=\"http://online.barrons.com/article/SB50001424052748704330804577138721268591622.html?mod=googlenews_wsj?mod=googlenews_barrons\">losing its competitive edge</a> and alienating investors as Weight Watchers (<a href='https://seekingalpha.com/symbol/WTW' title='Weight Watchers International, Inc.'>WTW</a> <font color=\"red\">-0.5%</font>) runs away with the business. The stock has fallen 50% over the past 12 months, and could easily fall another 20% from current levels. <div class=\"tiny-share-widget\" data-id=\"109042\" data-linked=\"Medifast (MED -2.9%) dips after an article in Barron&#39;s over the weekend says the company is...\" data-tweet=\"$MED $MED $WW - Medifast (MED -2.9%) dips after an article in Barron&#39;s over the weekend says the company is losing its competitive edge and alienating investors as Weight Watchers (WTW -0.5%) runs away with the business. The stock has fallen 50% over th... https://seekingalpha.com/news/109042?source=tweet\" data-url=\"https://seekingalpha.com/news/109042\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109041\" data-ts=\"1326122970\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/F\" target=\"_blank\">F</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109041\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ford (F +1.5%) CEO Alan Mulally tells CNBC the firm expects auto industry sales to hit 13.5M-14M...</a></h4> Ford (<a href='https://seekingalpha.com/symbol/F' title='Ford Motor Company'>F</a> <font color=\"green\">+1.5%</font>) CEO Alan Mulally <a target=\"_blank\" href=\"https://twitter.com/#!/CNBCbrk/status/156386958027915264\" target=\"_blank\">tells</a> CNBC the firm expects auto industry sales to hit 13.5M-14M vehicles this year, coming in on the upper end or exceeding the expectations of market watchers (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/107038\" target=\"_blank\">I</a>, <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/107597\" target=\"_blank\">II</a>). <div class=\"tiny-share-widget\" data-id=\"109041\" data-linked=\"Ford (F +1.5%) CEO Alan Mulally tells CNBC the firm expects auto industry sales to hit 13.5M-14M...\" data-tweet=\"$F $CARZ $VROM - Ford (F +1.5%) CEO Alan Mulally tells CNBC the firm expects auto industry sales to hit 13.5M-14M vehicles this year, coming in on the upper end or exceeding the expectations of market watchers (I, II). https://seekingalpha.com/news/109041?source=tweet\" data-url=\"https://seekingalpha.com/news/109041\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109038\" data-ts=\"1326122755\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANF\" target=\"_blank\">ANF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109038\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abercrombie &amp;amp; Fitch (ANF -2%) dips after Brean Murray cuts the shares to Hold, citing weak...</a></h4> Abercrombie &amp; Fitch (<a href='https://seekingalpha.com/symbol/ANF' title='Abercrombie & Fitch'>ANF</a> <font color=\"red\">-2%</font>) dips after Brean Murray <a target=\"_blank\" href=\"http://www.theflyonthewall.com/content_index.php?symbol=anf&amp;days_back=30&amp;table=none\">cuts the shares</a> to Hold, citing weak holiday sales and high discounting from its peers, plus economic uncertainty that could impact international sales. <div class=\"tiny-share-widget\" data-id=\"109038\" data-linked=\"Abercrombie &amp;amp; Fitch (ANF -2%) dips after Brean Murray cuts the shares to Hold, citing weak...\" data-tweet=\"$ANF - Abercrombie &amp; Fitch (ANF -2%) dips after Brean Murray cuts the shares to Hold, citing weak holiday sales and high discounting from its peers, plus economic uncertainty that could impact international sales. https://seekingalpha.com/news/109038?source=tweet\" data-url=\"https://seekingalpha.com/news/109038\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109037\" data-ts=\"1326122638\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAKO\" target=\"_blank\">MAKO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109037\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mako Surgical (MAKO +10%) reports selling 18 of its RIO surgical platform systems during Q4, vs....</a></h4><p>Mako Surgical (<a href=\"https://seekingalpha.com/symbol/MAKO\" title=\"MAKO Surgical Corp.\">MAKO</a> <font color=\"green\">+10%</font>) reports selling 18 of its RIO surgical  platform systems during Q4, vs. 13 systems sold in  the year-ago period, and says 2,258 MAKOplasty procedures  were performed in Q4, a 25% increase Q/Q and 97% gain Y/Y. MAKO anticipates selling 56-62 RIO systems and 11K-13K procedures performed in 2012. </p><div class=\"tiny-share-widget\" data-id=\"109037\" data-linked=\"Mako Surgical (MAKO +10%) reports selling 18 of its RIO surgical platform systems during Q4, vs....\" data-tweet=\"$MAKO - Mako Surgical (MAKO +10%) reports selling 18 of its RIO surgical platform systems during Q4, vs. 13 systems sold in the year-ago period, and says 2,258 MAKOplasty procedures were performed in Q4, a 25% increase Q/Q and 97% gain Y/Y. MAKO anticip... https://seekingalpha.com/news/109037?source=tweet\" data-url=\"https://seekingalpha.com/news/109037\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109036\" data-ts=\"1326122570\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPEN\" target=\"_blank\">OPEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109036\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OpenTable (OPEN +7.1%) pounds out a gain on the strength of an upgrade from Barclays to...</a></h4><p>OpenTable (<a href=\"https://seekingalpha.com/symbol/OPEN\" title=\"OpenTable, Inc.\">OPEN</a> <font color=\"green\">+7.1%</font>) pounds out a gain on the strength of an <a target=\"_blank\" href=\"http://www.streetinsider.com/Upgrades/Barclays+Upgrades+OpenTable+%28OPEN%29+to+Overweight/7066696.html\">upgrade</a> from Barclays to Overweight from Equalweight, overlooking the $7 price target cut to $46 analysts with the firm lined up. </p><div class=\"tiny-share-widget\" data-id=\"109036\" data-linked=\"OpenTable (OPEN +7.1%) pounds out a gain on the strength of an upgrade from Barclays to...\" data-tweet=\"$OPEN - OpenTable (OPEN +7.1%) pounds out a gain on the strength of an upgrade from Barclays to Overweight from Equalweight, overlooking the $7 price target cut to $46 analysts with the firm lined up. https://seekingalpha.com/news/109036?source=tweet\" data-url=\"https://seekingalpha.com/news/109036\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109032\" data-ts=\"1326122037\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CFN\" target=\"_blank\">CFN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109032\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CareFusion (NYSE:CFN) dives 8.2% following its earnings warning, making its one of the biggest...</a></h4> CareFusion (NYSE:<a href='https://seekingalpha.com/symbol/CFN' title='CareFusion Corporation'>CFN</a>) <font color=\"red\">dives 8.2%</font> following its <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/108998\">earnings warning</a>, making its one of the biggest fallers in the S&amp;P 500. <div class=\"tiny-share-widget\" data-id=\"109032\" data-linked=\"CareFusion (NYSE:CFN) dives 8.2% following its earnings warning, making its one of the biggest...\" data-tweet=\"$CFN - CareFusion (NYSE:CFN) dives 8.2% following its earnings warning, making its one of the biggest fallers in the S&amp;P 500. https://seekingalpha.com/news/109032?source=tweet\" data-url=\"https://seekingalpha.com/news/109032\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109033\" data-ts=\"1326122016\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKAM\" target=\"_blank\">AKAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109033\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akamai (AKAM -1.8%) shares sink after Citigroup lowers its rating to Sell from Neutral, citing...</a></h4><p>Akamai (<a href=\"https://seekingalpha.com/symbol/AKAM\" title=\"Akamai Technologies, Inc.\">AKAM</a> <font color=\"red\">-1.8%</font>) shares sink after Citigroup <a target=\"_blank\" href=\"http://www.forbes.com/sites/ericsavitz/2012/01/09/akamai-citi-downgrades-rating-to-sell-shares-sink\">lowers its rating</a> to Sell from Neutral,  citing valuation after an \"overly aggressive\" stock price reaction to <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/107040\">last month's purchase</a> of Cotendo and greater competition from Amazon's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AMZN\" title=\"Amazon.com, Inc.\">AMZN</a>) CloudFront CDN business. On the Cotendo deal, it is \u201cnot clear that Cotendo will  provide Akamai material new products of market opportunities.\" </p><div class=\"tiny-share-widget\" data-id=\"109033\" data-linked=\"Akamai (AKAM -1.8%) shares sink after Citigroup lowers its rating to Sell from Neutral, citing...\" data-tweet=\"$AKAM $AKAM $AMZN - Akamai (AKAM -1.8%) shares sink after Citigroup lowers its rating to Sell from Neutral, citing valuation after an &quot;overly aggressive&quot; stock price reaction to last month&#39;s purchase of Cotendo and greater competition from Amazon&#39;s (NAS... https://seekingalpha.com/news/109033?source=tweet\" data-url=\"https://seekingalpha.com/news/109033\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109030\" data-ts=\"1326121714\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GME\" target=\"_blank\">GME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109030\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of GameStop (GME -4.9%) slide after the firm says it expects same-store sales for Q4 and...</a></h4><p>Shares of GameStop (<a href=\"https://seekingalpha.com/symbol/GME\" title=\"GameStop Corp.\">GME</a> <font color=\"red\">-4.9%</font>) slide after the firm says it expects same-store sales for Q4 and full-year 2011 to be down 1% to 2% after sales of new game titles only slightly offset a sharp decline in hardware sales over the holiday period. The firm notes that it retired the remainder of its long-term debt and starts off 2012 with a debt-free balance sheet.</p><div class=\"tiny-share-widget\" data-id=\"109030\" data-linked=\"Shares of GameStop (GME -4.9%) slide after the firm says it expects same-store sales for Q4 and...\" data-tweet=\"$GME - Shares of GameStop (GME -4.9%) slide after the firm says it expects same-store sales for Q4 and full-year 2011 to be down 1% to 2% after sales of new game titles only slightly offset a sharp decline in hardware sales over the holiday period. The ... https://seekingalpha.com/news/109030?source=tweet\" data-url=\"https://seekingalpha.com/news/109030\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109025\" data-ts=\"1326120967\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INVA\" target=\"_blank\">INVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109025\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Theravence (THRX -33.4%) crater after the firm&#39;s Phase III results for Relovair...</a></h4><p>Shares of Theravence (THRX <font color=\"red\">-33.4%</font>) crater after the firm's Phase III results for Relovair (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/108952\">previous</a>) includes the disclosure of pneumonia-related deaths in patients.</p><div class=\"tiny-share-widget\" data-id=\"109025\" data-linked=\"Shares of Theravence (THRX -33.4%) crater after the firm&#39;s Phase III results for Relovair...\" data-tweet=\"$INVA - Shares of Theravence (THRX -33.4%) crater after the firm&#39;s Phase III results for Relovair (previous) includes the disclosure of pneumonia-related deaths in patients. https://seekingalpha.com/news/109025?source=tweet\" data-url=\"https://seekingalpha.com/news/109025\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109022\" data-ts=\"1326120341\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENDP\" target=\"_blank\">ENDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109022\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The FDA issues a warning of &quot;potential safety risks&quot; associated with certain opiate products...</a></h4><p>The FDA <a target=\"_blank\" href=\"http://www.fda.gov/Drugs/DrugSafety/ucm286225.htm\">issues</a> a warning of \"potential safety risks\" associated with certain opiate products from Endo Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ENDP\" title=\"Endo International plc\">ENDP</a> <font color=\"red\">-1.3%</font>) after discovering a packaging problem that led to pills getting mixed in with different prescriptions.</p><div class=\"tiny-share-widget\" data-id=\"109022\" data-linked=\"The FDA issues a warning of &quot;potential safety risks&quot; associated with certain opiate products...\" data-tweet=\"$ENDP - The FDA issues a warning of &quot;potential safety risks&quot; associated with certain opiate products from Endo Pharmaceuticals (ENDP -1.3%) after discovering a packaging problem that led to pills getting mixed in with different prescriptions. https://seekingalpha.com/news/109022?source=tweet\" data-url=\"https://seekingalpha.com/news/109022\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109021\" data-ts=\"1326120311\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109021\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix (NFLX +2.9%) continues its recent rally after announcing the launch of its streaming...</a></h4><p>Netflix (<a href=\"https://seekingalpha.com/symbol/NFLX\" title=\"Netflix, Inc.\">NFLX</a> <font color=\"green\">+2.9%</font>) continues its <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/108832\">recent rally</a> after announcing the launch of its streaming service for the U.K. and Ireland. The company is offering the service for 5.99/month in the U.K and \u20ac6.99/month in Ireland, and has established a long list of <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/100937\">content partners</a>. However, concerns exist about Netflix's <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/103093\">licensing costs</a>, as well as <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/108839\">competition</a> from Amazon's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AMZN\" title=\"Amazon.com, Inc.\">AMZN</a>) Lovefilm subsidiary. </p><div class=\"tiny-share-widget\" data-id=\"109021\" data-linked=\"Netflix (NFLX +2.9%) continues its recent rally after announcing the launch of its streaming...\" data-tweet=\"$NFLX $NFLX $AMZN - Netflix (NFLX +2.9%) continues its recent rally after announcing the launch of its streaming service for the U.K. and Ireland. The company is offering the service for 5.99/month in the U.K and \u20ac6.99/month in Ireland, and has establi... https://seekingalpha.com/news/109021?source=tweet\" data-url=\"https://seekingalpha.com/news/109021\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109019\" data-ts=\"1326119897\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VVUS\" target=\"_blank\">VVUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109019\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vivus (VVUS +15.9%) shares surge after it says the FDA has asked the pharmaceutical company to...</a></h4><p>Vivus (<a href=\"https://seekingalpha.com/symbol/VVUS\" title=\"Vivus, Inc.\">VVUS</a> <font color=\"green\">+15.9%</font>) shares surge after it says the FDA has asked the pharmaceutical company to remove the restriction against use by women of childbearing age on the proposed label for the weight-loss drug Qnexa. </p><div class=\"tiny-share-widget\" data-id=\"109019\" data-linked=\"Vivus (VVUS +15.9%) shares surge after it says the FDA has asked the pharmaceutical company to...\" data-tweet=\"$VVUS - Vivus (VVUS +15.9%) shares surge after it says the FDA has asked the pharmaceutical company to remove the restriction against use by women of childbearing age on the proposed label for the weight-loss drug Qnexa. https://seekingalpha.com/news/109019?source=tweet\" data-url=\"https://seekingalpha.com/news/109019\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109006\" data-ts=\"1326118518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109006\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Market preview: S&amp;amp;P futures +0.2% while Europe is mixed, and the Swiss franc is rising...</a></h4><b>Market preview:</b> S&amp;P futures <font color=\"green\">+0.2%</font> while Europe is mixed, and the Swiss franc is rising against the dollar and the euro following the <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/109000\">resignation</a> of SNB Chairman Philipp Hildebrand. Inhibitex <font color=\"green\">+143%</font> on news it's being bought by Bristol-Myers Squibb for $2.5B and at a <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/108953\">massive premium</a>.  <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/108937\">Later:</a> Employment Trends Index, consumer credit, Alcoa <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/108990\">kicks off</a> earnings season. <div class=\"tiny-share-widget\" data-id=\"109006\" data-linked=\"Market preview: S&amp;amp;P futures +0.2% while Europe is mixed, and the Swiss franc is rising...\" data-tweet=\"Market preview: S&amp;P futures +0.2% while Europe is mixed, and the Swiss franc is rising against the dollar and the euro following the resignation of SNB Chairman Philipp Hildebrand. Inhibitex +143% on news it&#39;s being bought by Bristol-Myers Squibb for $2... https://seekingalpha.com/news/109006?source=tweet\" data-url=\"https://seekingalpha.com/news/109006\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109007\" data-ts=\"1326118375\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCHN\" target=\"_blank\">SCHN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109007\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Schnitzer Steel (NASDAQ:SCHN) -2.3% premarket after reporting FQ1 EPS of $0.25, beating...</a></h4><p>Schnitzer Steel (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SCHN\" title=\"Schnitzer Steel Industries, Inc.\">SCHN</a>) <font color=\"red\">-2.3%</font> premarket after reporting FQ1 EPS of $0.25, beating consensus by $0.03, and revenues of $812M, up 20.3% Y/Y, vs. consensus $787M. Operating margins \"compressed significantly as average inventory costs did not decline as quickly as cash purchase prices for scrap. which was  followed by a sharp decline in sales prices.\" </p><div class=\"tiny-share-widget\" data-id=\"109007\" data-linked=\"Schnitzer Steel (NASDAQ:SCHN) -2.3% premarket after reporting FQ1 EPS of $0.25, beating...\" data-tweet=\"$SCHN - Schnitzer Steel (NASDAQ:SCHN) -2.3% premarket after reporting FQ1 EPS of $0.25, beating consensus by $0.03, and revenues of $812M, up 20.3% Y/Y, vs. consensus $787M. Operating margins &quot;compressed significantly as average inventory costs did not ... https://seekingalpha.com/news/109007?source=tweet\" data-url=\"https://seekingalpha.com/news/109007\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"109001\" data-ts=\"1326117113\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLX\" target=\"_blank\">PLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/109001\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Protalix BioTherapeutics (NYSEMKT:PLX) gain 5.3% premarket after investors take a hard...</a></h4><p>Shares of Protalix BioTherapeutics (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/PLX\" title=\"Protalix BioTherapeutics, Inc\">PLX</a>) <font color=\"green\">gain 5.3%</font> premarket after investors take a hard look at biotech drug names following the <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/108953\">BMY-Inhibitex deal</a>. The firm is aiming to develop a groundbreaking Gaucher disease treatment.</p><div class=\"tiny-share-widget\" data-id=\"109001\" data-linked=\"Shares of Protalix BioTherapeutics (NYSEMKT:PLX) gain 5.3% premarket after investors take a hard...\" data-tweet=\"$PLX - Shares of Protalix BioTherapeutics (NYSEMKT:PLX) gain 5.3% premarket after investors take a hard look at biotech drug names following the BMY-Inhibitex deal. The firm is aiming to develop a groundbreaking Gaucher disease treatment. https://seekingalpha.com/news/109001?source=tweet\" data-url=\"https://seekingalpha.com/news/109001\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"108999\" data-ts=\"1326116452\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPCM\" target=\"_blank\">IPCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/108999\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IPC (NASDAQ:IPCM) extends AH losses from Friday following its Q4 earnings warning, tailing off...</a></h4><p>IPC (NASDAQ:<a href=\"https://seekingalpha.com/symbol/IPCM\" title=\"IPC The Hospitalist Company, Inc.\">IPCM</a>) extends AH losses from Friday following its <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/108901\">Q4 earnings warning</a>, <font color=\"red\">tailing off 21.6%</font> premarket. Jefferies <a target=\"_blank\" href=\"http://localizedusa.com/2012/01/09/ipc-the-hospitalist-ipcm-shares-downgraded-to-a-hold-rating-by-jefferies-group-jef-analysts/\">chimes in</a> after the report with a downgrade to Hold from Buy and a reduced price target of $40.</p><div class=\"tiny-share-widget\" data-id=\"108999\" data-linked=\"IPC (NASDAQ:IPCM) extends AH losses from Friday following its Q4 earnings warning, tailing off...\" data-tweet=\"$IPCM - IPC (NASDAQ:IPCM) extends AH losses from Friday following its Q4 earnings warning, tailing off 21.6% premarket. Jefferies chimes in after the report with a downgrade to Hold from Buy and a reduced price target of $40. https://seekingalpha.com/news/108999?source=tweet\" data-url=\"https://seekingalpha.com/news/108999\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"108993\" data-ts=\"1326115284\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RF\" target=\"_blank\">RF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/108993\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Regions Financial (NYSE:RF) +1.8% premarket after WSJ reported over the weekend that the bank is...</a></h4><p>Regions Financial (NYSE:<a href=\"https://seekingalpha.com/symbol/RF\" title=\"Regions Financial Corporation\">RF</a>) <font color=\"green\">+1.8%</font> premarket after <em>WSJ</em> reported over the weekend that the bank is <a target=\"_blank\" href=\"http://online.wsj.com/article/SB10001424052970204331304577145111493979068.html\">close to a deal to sell</a> its Morgan Keegan investment banking and brokerage unit for ~$1B. The price would be much less than the bank had once expected, and it isn't clear which of the reported bidders, Raymond James (NYSE:<a href=\"https://seekingalpha.com/symbol/RJF\" title=\"Raymond James Financial Inc.\">RJF</a>) or Stifel Financial (NYSE:<a href=\"https://seekingalpha.com/symbol/SF\" title=\"Stifel Financial Corporation\">SF</a>), is the favorite. </p><div class=\"tiny-share-widget\" data-id=\"108993\" data-linked=\"Regions Financial (NYSE:RF) +1.8% premarket after WSJ reported over the weekend that the bank is...\" data-tweet=\"$RF $RF $RJF - Regions Financial (NYSE:RF) +1.8% premarket after WSJ reported over the weekend that the bank is close to a deal to sell its Morgan Keegan investment banking and brokerage unit for ~$1B. The price would be much less than the bank had once... https://seekingalpha.com/news/108993?source=tweet\" data-url=\"https://seekingalpha.com/news/108993\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"108988\" data-ts=\"1326114738\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RHI\" target=\"_blank\">RHI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/108988\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barron&#39;s sees upside for Robert Half (NYSE:RHI) as more companies expand the use of temporary...</a></h4><p>Barron's <a target=\"_blank\" href=\"http://online.barrons.com/article/SB50001424052748704158404577140930801232846.html\">sees upside</a> for Robert Half (NYSE:<a href=\"https://seekingalpha.com/symbol/RHI\" title=\"Robert Half International Inc.\">RHI</a>) as more companies expand the use of temporary workers amid economic uncertainty. A positive article over the weekend cites one portfolio manager who calls for a clean double in RHI's value within a year or two on the staffing industry bounce. Shares <font color=\"green\">+1.1%</font> premarket. \n</p><div class=\"tiny-share-widget\" data-id=\"108988\" data-linked=\"Barron&#39;s sees upside for Robert Half (NYSE:RHI) as more companies expand the use of temporary...\" data-tweet=\"$RHI - Barron&#39;s sees upside for Robert Half (NYSE:RHI) as more companies expand the use of temporary workers amid economic uncertainty. A positive article over the weekend cites one portfolio manager who calls for a clean double in RHI&#39;s value within a ... https://seekingalpha.com/news/108988?source=tweet\" data-url=\"https://seekingalpha.com/news/108988\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"108983\" data-ts=\"1326114116\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNK\" target=\"_blank\">MNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/108983\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Questcor Pharmaceuticals (QCOR) shoot up 5.4% premarket after the firm reports it...</a></h4><p>Shares of Questcor Pharmaceuticals (QCOR) shoot <font color=\"green\">up 5.4%</font> premarket after the firm reports it shipped double the number of its MS-treatment Acthar prescription last year than it did in 2010. </p><div class=\"tiny-share-widget\" data-id=\"108983\" data-linked=\"Shares of Questcor Pharmaceuticals (QCOR) shoot up 5.4% premarket after the firm reports it...\" data-tweet=\"$MNK - Shares of Questcor Pharmaceuticals (QCOR) shoot up 5.4% premarket after the firm reports it shipped double the number of its MS-treatment Acthar prescription last year than it did in 2010. https://seekingalpha.com/news/108983?source=tweet\" data-url=\"https://seekingalpha.com/news/108983\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"108974\" data-ts=\"1326112634\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDIX\" target=\"_blank\">IDIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/108974\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Idenix Pharmaceuticals (NASDAQ:IDIX) strikes while the iron is hot, reporting positive data from...</a></h4><p>Idenix Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/IDIX\" title=\"Idenix Pharmaceuticals, Inc.\">IDIX</a>) strikes while the iron is hot, reporting positive data from a Phase IIb clinical trial of its Hepatitis C treatment IDX184 just as <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/108962\">M&amp;A buzz</a> in the sector picks up in force. Shares <font color=\"green\">+28.7%</font> premarket. </p><div class=\"tiny-share-widget\" data-id=\"108974\" data-linked=\"Idenix Pharmaceuticals (NASDAQ:IDIX) strikes while the iron is hot, reporting positive data from...\" data-tweet=\"$IDIX - Idenix Pharmaceuticals (NASDAQ:IDIX) strikes while the iron is hot, reporting positive data from a Phase IIb clinical trial of its Hepatitis C treatment IDX184 just as M&amp;A buzz in the sector picks up in force. Shares +28.7% premarket. https://seekingalpha.com/news/108974?source=tweet\" data-url=\"https://seekingalpha.com/news/108974\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:37 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1576645200,"end":1576731599,"str":"Wednesday, December 18, 2019"},"yesterday":{"start":1576558800,"end":1576645199}}